Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers-Reference-Cited by-同舟云学术

Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers

Published:2016-03-09 Issue:15 Volume:7 Page:20773-20787
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Bradford James R.¹,Wappett Mark²,Beran Garry²,Logie Armelle²,Delpuech Oona²,Brown Henry²,Boros Joanna²,Camp Nicola J.³,McEwen Robert²,Mazzola Anne Marie⁴,D’Cruz Celina⁴,Barry Simon T.²

Affiliation:

1. Department of Oncology and Metabolism, University of Sheffield, Sheffield, South Yorkshire, UK

2. Oncology iMED, AstraZeneca Pharmaceuticals, Alderley Park, Cheshire, UK

3. Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA

4. Oncology iMED, AstraZeneca Pharmaceuticals, Gatehouse Park, Massachusetts, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zebrafish Xenographs in Oncology and Personalized Medicine;Molecular Biology;2024-06

2. Generation, evolution, interfering factors, applications, and challenges of patient-derived xenograft models in immunodeficient mice;Cancer Cell International;2023-06-21

3. Orthotopic PDX and CDX Mice Model for Cancer Stem Cell Research;Handbook of Animal Models and its Uses in Cancer Research;2023

4. The Barretos Cancer Hospital Animal Facility: Implementation and Results of a Dedicated Platform for Preclinical Oncology Models;Veterinary Sciences;2022-11-16

5. Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer;BMC Cancer;2022-04-12